89 / 100 SEO Score
Cambridge Rare Disease Network - CRDN | Our Activities | Companies Forum 1

Companies Forum

an opportunity to network and collaborATE

CRDN Companies Forum meetings welcome representatives from pharmaceutical, biotechnology and healthcare companies operating in the rare disease space who are interested in understanding the regulatory environment for orphan medicinal products and working collaboratively on projects. 

Meetings are conducted under Chatham House Rules and held  three times a year. Content for discussion is agreed amongst the group and high calibre speakers sourced by CRDN. Meetings are a half to full day,  informative, relaxed and collaborative and members receive presented slides and minutes of the meeting for future reference.

COMPANIES FORUM MEMBERS INCLUDE:

Abcam logo
Alexion logo
Atlantic research group logo
Congenica Logo
EAHSN master logo
Healx Logo
Illumina logo
lifearc logo
Cambridge Rare Disease Network - CRDN | Our Activities | Companies Forum 2
Pfizer Logo
pulse infoframe logo
SOBI logo
Takeda logo

UPCOMING 2020 MEETINGS

9 October 2020
Rare Disease Clinical Trials in the COVID/post-COVID environment

The discussion will explore decentralised trials, wearable technology, remote monitoring and protecting vulnerable patients

Venue: Virtual platform

Speakers:

Steven Anderson, CSO, Covance Global CRO

Elin Haf-Davies, CEO, Aperito

Senior Regulator for MHRA CliicalTrails Unit tbc

SPRING 2020 MEETING - 6 MAR

Venue: Royal Society of Medicine, London

Speakers: Professor Ron Akehurst,  Uni of Sheffield and  Sheela Upadhyaya,  HST and Topic Selection Specialist.  National Institute for Health and Care Excellence

AUTUMN 2019 MEETING - 29 NOV

Venue: Royal Society of Medicine, London 

Speakers: Prof Chas Bountra – University of Oxford, Dan Lewi – CATs Foundation, Tess Harris – PKD  UK, Allison Watson – Ring20 Research

Ron-Jortner-networking-CRDN-Companies-Forum-2020
Allison Watson Ring 20 Research & Support Companies forum
Jonathan-Milner-CRDN-Trustee-at-Companies-Forum

CAN CRDN’S COMPANIES FORUM 2020 CONNECT THE DOTS?

Read CRDN’s blog exploring how our Companies Forum is seeking to challenge the status quo in orphan therapeutic development and support companies to connect the dots 

pharmaphorum logo

Pharmaphorum’s George Underwood talks to CRDN Companies Forum lead Dr. Ron Jortner about the biggest challenges facing rare disease pharma, and how the industry can tackle them.

WP Feedback

Dive straight into the feedback!
Login below and you can start commenting using your own user instantly

CRDN sign up to newsletter

Sign up to our monthly newsletter packed with news & events. Join our thriving rare disease community.

 

You have Successfully Subscribed!